June 12, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Gilead Sciences, Inc. (“Gilead” or “the Company”) (NASDAQ: GILD). Investors who purchased Gilead securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Gilead has violated… read more
June 12, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Reddit, Inc. (“Reddit” or “the Company”) (NYSE: RDDT). Investors who purchased Reddit securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Reddit has violated federal… read more
June 10, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Abacus Global Management, Inc. (“Abacus” or “the Company”) (NASDAQ: ABL). Investors who purchased Abacus securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Abacus has… read more
June 9, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of NWTN Inc. (“NWTN” or “the Company”) (NASDAQ: NWTN). Investors who purchased NWTN securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether NWTN has violated federal… read more
June 9, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Brown-Forman Corporation (“Brown-Forman” or “the Company”) (NYSE: BF-A, BF-B). Investors who purchased Brown-Forman securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Brown-Forman has violated… read more
June 9, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bausch + Lomb Corporation (“Bausch + Lomb” or “the Company”) (NYSE: BLCO). Investors who purchased Bausch + Lomb securities are encouraged to obtain additional information and assist the investigation. The investigation… read more
June 4, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of New Fortress Energy, Inc. (“New Fortress” or “the Company”) (NASDAQ: NFE). Investors who purchased New Fortress securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
May 29, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of NeuroPace, Inc. (“NeuroPace” or “the Company”) (NASDAQ: NPCE). Investors who purchased NeuroPace securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether NeuroPace has violated federal… read more
May 28, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Tempus AI, Inc. (“Tempus” or “the Company”) (NASDAQ: TEM). Investors who purchased Tempus securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Tempus has violated… read more
May 28, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of AlloVir Inc. (“AlloVir” or “the Company”) (NASDAQ: ALVR). Investors who purchased AlloVir securities prior to March 22, 2022, and continue to hold to the present, are encouraged to obtain additional information… read more
May 28, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Semler Scientific, Inc. (“Semler” or “the Company”) (NASDAQ: SMLR). Investors who purchased Semler securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Semler has violated… read more
May 27, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Luminar Technologies, Inc. (“Luminar” or “the Company”) (NASDAQ: LAZR). Investors who purchased Luminar securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Luminar has violated… read more
May 27, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ADTRAN Holdings, Inc. (“ADTRAN” or “the Company”) (NASDAQ: ADTN). Investors who purchased ADTRAN securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether ADTRAN has violated… read more
May 26, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Edison International (“Edison” or “the Company”) (NYSE: EIX). Investors who purchased Edison securities prior to February 25, 2021, and continue to hold to the present, are encouraged to obtain additional information… read more
May 26, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fulgent Genetics, Inc. (“Fulgent” or “the Company”) (NASDAQ: FLGT). Investors who purchased Fulgent securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Fulgent has violated… read more
May 26, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Flowco Holdings Inc. (“Flowco” or “the Company”) (NYSE: FLOC). Investors who purchased Flowco securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Flowco has violated… read more
May 22, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Schrödinger, Inc. (“Schrödinger” or “the Company”) (NASDAQ: SDGR). Investors who purchased Schrödinger securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Schrödinger has violated federal… read more
May 20, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Travere Therapeutics, Inc. (“Travere” or “the Company”) (NASDAQ: TVTX). Investors who purchased Travere securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Travere has violated… read more
May 20, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Apple Inc. (“Apple” or “the Company”) (NASDAQ: AAPL). Investors who purchased Apple securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Apple has violated federal… read more
May 19, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Meta Platforms, Inc. (“Meta” or “the Company”) (NASDAQ: META). Investors who purchased Meta securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Meta has violated… read more
May 19, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Capricor Therapeutics, Inc. (“Capricor” or “the Company”) (NASDAQ: CAPR). Investors who purchased Capricor securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Capricor has violated… read more
May 19, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GoHealth, Inc. (“GoHealth” or “the Company”) (NASDAQ: GOCO). Investors who purchased GoHealth securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether GoHealth has violated federal… read more
May 16, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Metallus Inc. (“Metallus” or “the Company”) (NYSE: MTUS). Investors who purchased Metallus securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Metallus has violated federal… read more
May 16, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Integra LifeSciences Holdings Corporation (“Integra” or “the Company”) (NASDAQ: IART). Investors who purchased Integra securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Integra has… read more
May 16, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Senti Biosciences, Inc. (“Senti” or “the Company”) (NASDAQ: SNTI). Investors who purchased Senti securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Senti has violated… read more
May 15, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GrafTech International Ltd. (“GrafTech” or “the Company”) (NYSE: EAF). Investors who purchased GrafTech securities prior to February 8, 2019, and continue to hold to the present, are encouraged to obtain additional… read more
May 15, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Bancorp, Inc. (“Bancorp” or “the Company”) (NASDAQ: TBBK). Investors who purchased Bancorp securities prior to January 25, 2024, and continue to hold to the present, are encouraged to obtain additional… read more
May 15, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Coinbase Global, Inc. (“Coinbase” or “the Company”) (NASDAQ: COIN). Investors who purchased Coinbase securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Coinbase has violated… read more
May 15, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Take-Two Interactive Software, Inc. (“Take-Two” or “the Company”) (NASDAQ: TTWO). Investors who purchased Take-Two securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Take-Two has… read more
May 14, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cleveland-Cliffs Inc. (“Cleveland-Cliffs” or “the Company”) (NYSE: CLF). Investors who purchased Cleveland-Cliffs securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Cleveland-Cliffs has violated federal… read more
